| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $54.63B | $54.21B | $52.79B |
| YoY Revenue Growth % | +0.8% | +2.7% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.47B | $2.61B | $3.03B |
| Operating Margin % | 2.7% | 4.8% | 5.7% |
| Net Income (GAAP) | $111.0M | $846.0M | $822.0M |
| EBITDA (Normalized) | $3.43B | $4.57B | $4.93B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.10B | $3.98B | $3.80B |
| Capital Expenditures (CapEx) | $2.46B | $2.44B | $2.38B |
| Free Cash Flow (FCF) | $640.5M | $1.54B | $1.43B |
| FCF Margin % | 1.2% | 2.8% | 2.7% |
| Return on Invested Capital (ROIC %) | 29.5% | 56.1% | 6.3% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $14.46B | $14.46B | $14.82B |
| Total Stockholders' Equity | -$3.73B | -$3.98B | $30.41B |